Inhalable, large porous PLGA microparticles loaded with paclitaxel: preparation, in vitro and in vivo characterization

References

• Alipour S, Montaseri H, Tafaghodi M. Preparation and characterization of biodegradable paclitaxel loaded alginate microparticles for pulmonary delivery. Colloids Surf B, 2010;81:521–9
   PubMed Web of Science ®Google Scholar
• Arnold MM, Gorman EM, Schieber LJ, Munson EJ, Berkland C. NanoCipro encapsulation in monodisperse large porous PLGA microparticles. J Controlled Release, 2007;121:100–9
   PubMed Web of Science ®Google Scholar
• Azarmi S, Tao X, Chen H, Wang Z, Finlay WH, Löbenberg R, Roa WH. Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles. Int J Pharm, 2006;319:155–61
   PubMed Web of Science ®Google Scholar
• Bai L, Zhu R, Chen Z, Gao L, Zhang X, Wang X, Bai C. Potential role of short hairpin RNA targeting epidermal growth factor receptor in growth and sensitivity to drugs of human lung adenocarcinoma cells. Biochem Pharmaco, 2006;71:1265–71
   PubMed Web of Science ®Google Scholar
• Choi J-S, Shin S-C. Enhanced paclitaxel bioavailability after oral coadministration of paclitaxel prodrug with naringin to rats. Int J Pharm, 2005;292:149–56
   PubMed Web of Science ®Google Scholar
• Chow A, Tong H, Chattopadhyay P, Shekunov B. Particle engineering for pulmonary drug Delivery. Pharm Res, 2007;24:411–37
   PubMed Web of Science ®Google Scholar
• Danhier F, Lecouturier N, Vroman B, Jerome C, Marchand-Brynaert J, Feron O, Preat V. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation. J Controlled Release, 2009;133:11–17
   PubMed Web of Science ®Google Scholar
• Devi TSR, Gayathri S. FTIR and FT-RAMAN Spectral analysis of paclitaxel drugs. Int J Pharm Sci Rev Res, 2010;2:106–10
   Google Scholar
• Dhanikula A, Panchagnula R. Development and characterization of biodegradable chitosan films for local delivery of paclitaxel. AAPS J, 2004;6:88–99
   Web of Science ®Google Scholar
• Doan TVP, Olivier JC. Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization. Int J Pharm, 2009;382:61–6
   PubMed Web of Science ®Google Scholar
• Edwards DA, Hanes J, Caponetti G, Hrkach J, Ben-Jebria A, Eskew ML, Mintzes JD, Deaver D, Lotan N, Langer R. Large porous particles for pulmonary drug delivery. Science, 1997;276:1688–71
   Google Scholar
• El-Gendy N, Berkland C. Combination Chemotherapeutic Dry Powder Aerosols via Controlled Nanoparticle Agglomeration. Pharm Res, 2009;26:1752–63
   PubMed Web of Science ®Google Scholar
• Elkharraz K, Faisant N, Guse C, Siepmann F, Arica-Yegin B, Oger JM, Gust R, Goepferich A, Benoit J. P, Siepmann J. Paclitaxel-loaded microparticles and implants for the treatment of brain cancer: Preparation and physicochemical characterization. Int Pharm, 2006;314:127–36
   PubMed Web of Science ®Google Scholar
• Gagnadoux F, Hureaux J, Vecellio L, Urban T, Le Pape A, Valo I, Montharu J, Leblond V, Boisdron-Celle M, Lerondel S, et al. Aerosolized chemotherapy. J Aerosol Med Pulm Drug Deliv, 2008;21:61–9
   PubMed Web of Science ®Google Scholar
• Giovannetti E, Mey V, Danesi R, Basolo F, Barachini S, Deri M, Del Tacca M. Interaction between gemcitabine and topotecan in human non-small-cell lung cancer cells: effects on cell survival, cell cycle and pharmacogenetic profile. Br J Cancer, 2005;92:681–9
   PubMed Web of Science ®Google Scholar
• Grenha A, Grainger CI, Dailey LA, Seijo B, Martin GP, Remuñán-López C, FORBES B. Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro. Eur J Pharm Sci, 2007;31:73–84
   PubMed Web of Science ®Google Scholar
• Gupte A, Ciftci K. Formulation and characterization of Paclitaxel, 5-FU and Paclitaxel + 5-FU microspheres. Int J Pharm, 2004;276:93–106
   PubMed Web of Science ®Google Scholar
• Hamoudeh M, Diab R, Fessi H, Dumontet C, Cuchet D. Paclitaxel-loaded microparticles for intratumoral administration via the TMT technique: preparation, characterization, and preliminary antitumoral evaluation. Drug Dev Ind Pharm, 2008;34:698–707
   PubMed Web of Science ®Google Scholar
• Hershey AE, Kurzman ID, Forrest LJ, Bohling CA, Stonerook M, Placke ME, Imondi AR, Vail DM. Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: proof of principle using dogs with spontaneously occurring tumors as a model. Clin Cancer Res, 1999;5:2653–29
   PubMed Web of Science ®Google Scholar
• Kang BK, Chon SK, Kim SH, Jeong SY, Kim MS, Cho SH, Lee HB, Khang G. Controlled release of paclitaxel from microemulsion containing PLGA and evaluation of anti-tumor activity in vitro and in vivo. Int J Pharm, 2004;286:147–56
   PubMed Web of Science ®Google Scholar
• Kano Y, Akutsu M, Tsunoda S, Ando J, Matsui J, Suzuki K, Ikeda T, Inoue Y, Adachi K. Schedule-dependent interaction between paclitaxel and 5-fluorouracil in human carcinoma cell lines in vitro. Brit J Cancer, 1996;74:704–10
   PubMed Web of Science ®Google Scholar
• Kim I, Byeon HJ, Kim TH, Lee ES, Oh KT, Shin BS, Lee KC, Youn YS. Doxorubicin-loaded highly porous large PLGA microparticles as a sustained- release inhalation system for the treatment of metastatic lung cancer. Biomaterials, 2012;33:5574–83
   PubMed Web of Science ®Google Scholar
• Koshkina NV, Waldrep JC, Roberts LE, Golunski E, Melton S, Knight V. Paclitaxel liposome aerosol treatment induces inhibition of pulmonary metastases in murine renal carcinoma model. Clin Cancer Res, 2001;7:3258–62
   PubMed Web of Science ®Google Scholar
• Li H-Y, Seville P. C.Novel pMDI formulations for pulmonary delivery of proteins. Int J Pharm, 2010;385:73–8
   PubMed Web of Science ®Google Scholar
• Liu X-B, Ye J-X, Quan L-H, Liu C-Y, Deng X-L, Yang M, Liao Y-H. Pulmonary delivery of scutellarin solution and mucoadhesive particles in rats. Eur J Pharm Sci, 2008;70:845–52
   Google Scholar
• Liu Y, Chen G-S, Chen Y, Cao D-X, Ge Z-Q, Yuan Y-J. Inclusion complexes of paclitaxel and oligo(ethylenediamino) bridged bis(β-cyclodextrin)s: Solubilization and antitumor activity. Bioorg Med Chem, 2004;12:5767–75
   PubMed Web of Science ®Google Scholar
• Malingre MM, Schellens JH, Van Tellingen O, Ouwehand M, Bardelmeijer HA, Rosing H, Koopman FJ, Schot ME, Bokkel THWW, Beijnen JH. The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients. Br J Cancer, 2001;85:1472–7
   PubMed Web of Science ®Google Scholar
• Mladenovska K, Cruaud O, Richomme P, Belamie E, Raicki RS, Venier-Julienne MC, Popovski E, Benoit JP. Goracinova K.5-ASA loaded chitosan-Ca-alginate microparticles: Preparation and physicochemical characterization. Int J Pharm, 2007;345:59–69
   PubMed Web of Science ®Google Scholar
• Murillo M, Gamazo C, Goni M, Irache J, Blanco-Prieto M. Development of microparticles prepared by spray-drying as a vaccine delivery system against brucellosis. Int J Pharm, 2002;242:341–4
   PubMed Web of Science ®Google Scholar
• Musumeci T, Vicari L, Ventura C, Gulisano M, Pignatello R, Puglisi G. Lyoprotected nanosphere formulations for paclitaxel controlled delivery. J Nanosci Nanotechnol, 2006;6:3118–25
   PubMed Web of Science ®Google Scholar
• Naikwade S, Bajaj A, Gurav P, Gatne M, Singh Soni P. Development of budesonide microparticles using spray-drying technology for pulmonary administration: design, characterization, in vitro evaluation and in vivo efficacy study. AAPS Pharm Sci Tech, 2009;10:993–1012
   PubMed Web of Science ®Google Scholar
• Oh YJ, Lee J, Seo JY, Rhim T, Kim S-H, Yoon HJ, Lee KY. Preparation of budesonide-loaded porous PLGA microparticles and their therapeutic efficacy in a murine asthma model. J Controlled Release, 2011;150:56–62
   PubMed Web of Science ®Google Scholar
• Okamoto H, Aoki M, Danjo K. A novel apparatus for rat in vivo evaluation of dry powder formulations for pulmonary administration. J Pharm Sci, 2000;89:1028–35
   PubMed Web of Science ®Google Scholar
• Qu G, Yao Z, Zhang C, Wu X, Ping Q. PEG conjugated N-octyl-O-sulfate chitosan micelles for delivery of paclitaxel: In vitro characterization and in vivo evaluation. Eur J Pharm Sci, 2009;37:98–105
   PubMed Web of Science ®Google Scholar
• Renke-Gluszko SMS, Wintermantel E, Albert AKA, Vogeser SM, Behnisch B, Schratzenstaller T. MagdalenaInhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating. Arterioscler Thromb Vasc Biol, 2005;25:748–53
   PubMed Web of Science ®Google Scholar
• Rocci ML JR, Jusko WJ. LAGRAN program for area and moments in pharmacokinetic analysis. Comput Programs Biomed, 1983;16:203–16
   PubMedGoogle Scholar
• Shah N, Chaudhari K, Dantuluri P, Murthy R. S, Das S. Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic ® P85, an in vitro cell line and in vivo biodistribution studies on rat model. J Drug Target, 2009;17:533–42
   PubMed Web of Science ®Google Scholar
• Singla AK, Garg A, Aggarwal D. Paclitaxel and its formulations. Int J Pharm, 2002;235:179–92
   PubMed Web of Science ®Google Scholar
• Sun ML, Wei JM, Wang XW, Li L, Wang P, Li M, Yi CH. Paclitaxel-octreotide conjugates inhibit growth of humannon-small cell lung cancer cells in vitro. Exp Oncol, 2007;29:186–91
   PubMedGoogle Scholar
• Taki M, Marriott C, Zeng X-M, Martin GP. Aerodynamic deposition of combination dry powder inhaler formulations in vitro: A comparison of three impactors. Int J Pharm, 2010;388:40–51
   PubMed Web of Science ®Google Scholar
• Ungaro F, Giovino C, Coletta C, Sorrentino R, Miro A, Quaglia F. Engineering gas-foamed large porous particles for efficient local delivery of macromolecules to the lung. Er J Pharm Sci, 2010;41:60–70
   Google Scholar
• Win KY, Feng S-S. In vitro and in vivo studies on vitamin E TPGS-emulsified poly(d,l-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation. Biomaterials, 2006;27:2285–91
   PubMed Web of Science ®Google Scholar
• Yang Y, Bajaj N, Xu P, Ohn K, Tsifansky MD, Yeo Y. Development of highly porous large PLGA microparticles for pulmonary drug delivery. Biomaterials, 2009;30:1947–53
   PubMed Web of Science ®Google Scholar
• Zhang C, Qu G, Sun Y, Wu X, Yao Z, Guo Q, Ding Q, Yuan S, Shen Z, Ping Q, Zhou H. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel. Biomaterials, 2008a;29:1233–41
   PubMed Web of Science ®Google Scholar
• Zhang LJ, Xing B, Wu J, Xu B, Fang XL. Biodistribution in mice and severity of damage in rat lungs following pulmonary delivery of 9-nitrocamptothecin liposomes. Pulm Pharmacol Ther, 2008b;21:239–46
   PubMed Web of Science ®Google Scholar